Taiwan FDA registration 02f15791ec5b8b3a5279feeaa41d6d4b
"Qiaolian" electrolyte analysis system
TW: "喬聯" 電解質分析系統
Taiwan·Risk Class 2·Qiaolian Technology Co., Ltd. Nankan Factory·Registered Jun 13, 2024 – Jun 13, 2029ActiveRegistration details
- Analysis ID
- 02f15791ec5b8b3a5279feeaa41d6d4b
Company information
- Manufacturer
- Qiaolian Technology Co., Ltd. Nankan Factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BIOCARE CORPORATION
Product details
- Intended Use
- This product is intended for in vitro diagnostics by professionals for the quantitative determination of sodium, potassium, chloride and calcium in serum, plasma and whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1145 鈣試驗系統;; A.1665 鈉試驗系統;; A.0002 臨床化學離子分析儀
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Jun 13, 2024
- Expiry Date
- Jun 13, 2029
About this record
Access comprehensive regulatory information for "Qiaolian" electrolyte analysis system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 02f15791ec5b8b3a5279feeaa41d6d4b and manufactured by Qiaolian Technology Co., Ltd. Nankan Factory. The authorized representative in Taiwan is BIOCARE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices